These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 30733156)

  • 1. Incidence, predictors, and outcomes after severe primary graft dysfunction in pediatric heart transplant recipients.
    Profita EL; Gauvreau K; Rycus P; Thiagarajan R; Singh TP
    J Heart Lung Transplant; 2019 Jun; 38(6):601-608. PubMed ID: 30733156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Factors for Severe Primary Graft Dysfunction in Infants Following Heart Transplant.
    Singh TP; Profita EL; Rycus P; Thiagarajan R; Gauvreau K
    J Am Heart Assoc; 2021 Jul; 10(13):e021082. PubMed ID: 34184543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved outcomes from extracorporeal membrane oxygenation versus ventricular assist device temporary support of primary graft dysfunction in heart transplant.
    Takeda K; Li B; Garan AR; Topkara VK; Han J; Colombo PC; Farr MA; Naka Y; Takayama H
    J Heart Lung Transplant; 2017 Jun; 36(6):650-656. PubMed ID: 28087104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The International Consortium on Primary Graft Dysfunction: Redefining Clinical Risk Factors in the Contemporary Era of Heart Transplantation.
    Moayedi Y; Truby LK; Foroutan F; Han J; Guzman J; Angleitner P; Sabatino M; Felius J; VAN Zyl JS; Rodenas-Alesina E; Fan CP; Devore AD; Miller R; Potena L; Zuckermann A; Farrero M; Chih S; Farr M; Hall S; Ross HJ; Khush KK
    J Card Fail; 2024 Jun; 30(6):805-815. PubMed ID: 37907150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case series: the outcomes, support duration, and graft function recovery after VA-ECMO use in primary graft dysfunction after heart transplantation.
    Kawabori M; Mastroianni MA; Zhan Y; Chen FY; Rastegar H; Warner KG; Reich JA; Vest A; DeNofrio D; Couper GS
    J Artif Organs; 2020 Jun; 23(2):140-146. PubMed ID: 31713054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of severe primary graft dysfunction in patients bridged to heart transplantation with continuous-flow left ventricular assist devices.
    Truby LK; Takeda K; Topkara VK; Takayama H; Garan AR; Yuzefpolskaya M; Colombo P; Naka Y; Farr M
    J Heart Lung Transplant; 2018 Dec; 37(12):1433-1442. PubMed ID: 30206023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Myocarditis an Independent Risk Factor for Post-Transplant Mortality in Pediatric Heart Transplant Recipients?
    Garbern JC; Gauvreau K; Blume ED; Singh TP
    Circ Heart Fail; 2016 Jan; 9(1):e002328. PubMed ID: 26699389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracorporeal membrane oxygenation as a salvage therapy for patients with severe primary graft dysfunction after heart transplant.
    Jacob S; Lima B; Gonzalez-Stawinski GV; El-Sayed Ahmed MM; Patel PC; Belli EV; Makey IA; Thomas M; Landolfo K; Landolfo C; Leoni Moreno JC; Yip DS; Pham SM
    Clin Transplant; 2019 May; 33(5):e13538. PubMed ID: 30870577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracorporeal membrane oxygenation use in the first 24 hours following pediatric heart transplantation: Incidence, risk factors, and outcomes.
    Godown J; Bearl DW; Thurm C; Hall M; Feingold B; Soslow JH; Mettler BA; Smith AH; Profita EL; Singh TP; Dodd DA
    Pediatr Transplant; 2019 Jun; 23(4):e13414. PubMed ID: 30973190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marginal cardiac allografts do not have increased primary graft dysfunction in alternate list transplantation.
    Lima B; Rajagopal K; Petersen RP; Shah AS; Soule B; Felker GM; Rogers JG; Lodge AJ; Milano CA
    Circulation; 2006 Jul; 114(1 Suppl):I27-32. PubMed ID: 16820584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term mechanical circulatory support for severe primary graft dysfunction following orthotopic heart transplant.
    Hulman M; Artemiou P; Ondrusek M; Hudec V; Gasparovic I; Bena M; Glonek I
    Interact Cardiovasc Thorac Surg; 2018 Aug; 27(2):229-233. PubMed ID: 29514222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PREDICTA: A Model to Predict Primary Graft Dysfunction After Adult Heart Transplantation in the United Kingdom.
    Avtaar Singh SS; DAS DE S; Rushton S; Berry C; Al-Attar N
    J Card Fail; 2019 Dec; 25(12):971-977. PubMed ID: 31330297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and impact of primary graft dysfunction in adult heart transplant recipients: A systematic review and meta-analysis.
    Buchan TA; Moayedi Y; Truby LK; Guyatt G; Posada JD; Ross HJ; Khush KK; Alba AC; Foroutan F
    J Heart Lung Transplant; 2021 Jul; 40(7):642-651. PubMed ID: 33947602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracorporeal membrane oxygenation support and post-heart transplant outcomes among United States adults.
    Zalawadiya S; Fudim M; Bhat G; Cotts W; Lindenfeld J
    J Heart Lung Transplant; 2017 Jan; 36(1):77-81. PubMed ID: 27866925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative Statin Therapy and Heart Transplantation Outcomes.
    Peled Y; Klempfner R; Kassif Y; Kogan A; Maor E; Sternik L; Lavee J; Ram E
    Ann Thorac Surg; 2020 Oct; 110(4):1280-1285. PubMed ID: 32156588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ISHLT Primary Graft Dysfunction Incidence, Risk Factors, and Outcome: A UK National Study.
    Avtaar Singh SS; Banner NR; Rushton S; Simon AR; Berry C; Al-Attar N
    Transplantation; 2019 Feb; 103(2):336-343. PubMed ID: 29757910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary Graft Dysfunction After Isolated Heart Transplantation　- Incidence, Risk Factors, and Clinical Implications Based on a Single-Center Experience.
    Rhee Y; Kim HJ; Kim JJ; Kim MS; Lee SE; Yun TJ; Lee JW; Jung SH
    Circ J; 2021 Aug; 85(9):1451-1459. PubMed ID: 33867405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of extracorporeal membrane oxygenation for heart graft dysfunction in adults: incidence, risk factors and outcomes in a multicentric study.
    Noly PE; Hébert M; Lamarche Y; Cortes JR; Mauduit M; Verhoye JP; Voisine P; Flécher E; Carrier M
    Can J Surg; 2021; 64(6):E567-E577. PubMed ID: 34728522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of medication non-adherence on survival after pediatric heart transplantation in the U.S.A.
    Oliva M; Singh TP; Gauvreau K; Vanderpluym CJ; Bastardi HJ; Almond CS
    J Heart Lung Transplant; 2013 Sep; 32(9):881-8. PubMed ID: 23755899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term Outcome in Severe Left Ventricular Primary Graft Dysfunction Post Cardiac Transplantation Supported by Early Use of Extracorporeal Membrane Oxygenation.
    Connolly S; Granger E; Hayward C; Huang D; Kerr S; McCanny P; Buscher H
    Transplantation; 2020 Oct; 104(10):2189-2195. PubMed ID: 31895346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.